Pharmacological agents and transport nanosystems based on plant phospholipids

Medvedeva N.V.1 , Prosorovskiy V.N.1, Ignatov D.V.1, Druzilovskaya O.S.1, Kudinov V.A.1, Kasatkina E.O.2, Tikhonova E.G.1, Ipatova O.M.1

1. Institute of Biomedical Chemistry, Moscow, Russia
2. IBMC-EcoBioPharm LLC, Moscow, Russia
Section: Review
DOI: 10.18097/PBMC20156102219      PubMed Id: 25978388
Year: 2015  Volume: 61  Issue: 2  Pages: 219-230
A new generation of plant phosphatidylcholine (PC)-based pharmacological agents has been developed under academician A.I. Archakov leadership at the Institute of Biomedical Chemistry (IBMC). For their production a unique technology allowing to obtain dry lyophilized phospholipid nanoparticles of 30 nm was elaborated. The successful practical application of PC nanoparticles as a drug agent may be illustrated by Phosphogliv (oral and injection formulations). Being developed at IBMC for the treatment of liver diseases, including viral hepatitis, Phosphogliv (currently marketed by the “Pharmstandard” company) is approved for clinical application in 2000, and is widely used in medical practice. Based on the developed and scaled in IBMC technology of prerparation of ultra small size phospholipid nanoparticles without the use of detergents/surfactants and stabilizers another drug preparation, Phospholipovit, exhibiting pronounced hypolipidemic properties has been obtained. Recently completed preclinical studies have shown that PC nanoparticles of 20-30 nm activate reverse cholesterol transport (RCT) and in this context it is more active than well known foreign preparation Essentiale. Phospholipovit is now at the stage of clinical trials (phase 1 completed). PC was also used as a basis for the development of a transport nanosystem with a particles size of 20-25 nm in diameter and incorporation of various drug substances from various therapeutic groups. Using several drugs substances as an example, increased bioavailability and specific activity were demonstrated for the formulations equipped with such transport nanosystem. Formulations equipped with the transport nanosystems have been developed for such pharmacological agents as doxorubicin, rifampin, budesonide, chlorin E6, prednisone, and others.
Download PDF:  
Keywords: phosphatidylcholine, phospholipid nanoparticles, drug delivery nanosystem, targed delivery

Medvedeva, N. V., Prosorovskiy, V. N., Ignatov, D. V., Druzilovskaya, O. S., Kudinov, V. A., Kasatkina, E. O., Tikhonova, E. G., Ipatova, O. M. (2015). Pharmacological agents and transport nanosystems based on plant phospholipids. Biomeditsinskaya Khimiya, 61(2), 219-230.
This paper is also available as the English translation: 10.1134/S199075081503004X
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)